Features and analysis of the current problems with the use of NSAIDs in the Arab countries
DOI: https://doi.org/10.29296/25419218-2021-04-05
Issue:
4
Year:
2021
Musculoskeletal system diseases affect not only the elderly, but also the young who belong to the economically active population. These diseases are almost always accompanied by pain and limited mobility, which negatively affects quality of life and its expectancy, including those in Arab countries. Among the musculoskeletal system diseases, rheumatoid arthritis is widespread among low- and middle-income groups, especially among those with lower socioeconomic status. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mainstay of treatment for musculoskeletal diseases in the Arab countries. Elderly people (over 65 years old) take NSAIDs almost daily. At the same time, many patients do not have complete information about the drugs, their adverse reactions, interaction with other groups of drugs, and they do not know or cannot calculate the correct dosage of drugs and the frequency of their administration. Today, the main problems with the use of NSAIDs are associated with lack of patients’ awareness of their adverse reactions, drug interactions, and the possibility of further pharmacocorrection. The identified problems with the use of NSAIDs in the Arab countries suggest that selective anti-inflammatory drugs should be designed for systemic administration. They are characterized as drugs with the lowest spectrum of adverse reactions, the low frequency of administration and, as a result, can be recommended for patients with certain concomitant diseases, for example, those in the gastrointestinal tract, cardiovascular system, etc.
Keywords:
Arab countries
non-selective and selective nonsteroidal anti-inflammatory drugs (NSAIDs)
References:
- James S.L., Abate D., Abate K.H. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1789–858. Access mode: http: www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf
- The Impact of Musculoskeletal Disorders on Americans – Opportunities for Action. Bone and Joint Initiative USA. 2016. Access mode: http: www.boneandjointburden.org/docs/BMUSExecutiveSummary2016.pdf
- Brennan-Olsen S.L., Cook S., Leech M.T. et al. Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: analysis of data from the World Health Organization study on global AGEing and adult health (SAGE). Wave 1. BMC Musculoskeletal Disorders. 2017. Access mode: https: www.bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-017-1624-z
- World Health Organization. Guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva: WHO, 2017. Access mode: https: www.who.int/ageing/publications/guidelines-icope/en
- Albsoul-Younes A.M., Jabateh S.K., Abdel-Hafiz S.M. et al. Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the jordanian patient population. Saudi Med. J. 2004; 25: 907–11. Access mode: https: www.bit.ly/2GIa7Vp
- Gopal K., Rani V., Ganesh S. et al. Awareness of the adverse effects of NSAIDS among its buyers from community pharmacies. J. of pharmacy research. 2010; 3: 2890–3. Access mode: http: www.jprsolutions.info/newfiles/journal-file-55d610e0908214.44207354.pdf
- Wawryk-Gawda E., Chylinska-Wrzos P., Lis-Sochocka M. et al. Consumption and awareness of students about nonsteroidal anti-inflammatory drugs. Curr.Issues. Pharm. Med. Sci. 2014; 27: 175–8. Access mode: https: www.bit.ly/2XQQaTg
- Jamiu M.O., Giwa A., Abu-Saeed K. Assessment of Pattern of Non-steroidal Anti-Inflammatory Drugs (NSAIDS) Use Among Residents of A North Central Nigerian CityAssessment of Pattern of Non-steroidal Anti-Inflammatory Drugs (NSAIDS) Use Among Residents of A North Central Nigerian City. Tropical J. of Health Sciences. 2017; 24 (4): 1–4. Access mode: https: www.ajol.info/index.php/tjhc/article/view/164012
- Abougalambou S.S., Abdoun S.A., SayerAlharbi N. Awareness of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) use among population in Saudi Arabia. 2019. Access mode: https: www.ncbi.nlm.nih.gov/pmc/articles/PMC2042659
- Yilmaz H., Gürel S., Özdemīr O. Turkish patients with osteoarthritis: Their awareness of the side effects of NSAIDs. Turk. J. Gastroenterol. 2005; 16: 89–92. Access mode: https: www.bit.ly/2UGJiG9
- Wynne H., Long A. Patient awareness of the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs). British J. of Clinical Pharmacology. 1996; 42: 253–6. Access mode: https: www.bit.ly/2DzPaeA
- Hasan M.Y., Das, M., Bener A. Professional Advice and the Utilization of Non-Steroidal Anti-Inflammatory Drugs at Community Pharmacies in the United Arab Emirates. International Quarterly of Community Health Education. 2003; 21 (4): 377–88. Access mode: https: www.journals.sagepub.com/doi/abs/10.2190/TVYD-B2NB-21N1-X17L
- Sharif S.I., Al-Shaqra M., Hajjar H. et al. Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J. of Medicine. 2008; 3 (1): 10–2. Access mode: https: www.researchgate.net/publication/51073188_Patterns_Of_Drug_Prescribing_In_A_Hospital_In_Dubai_United_Arab_Emirates
- Alshakka M.A., Badullah W.F., Alolayan S.O., Mahmoud M.A. Prescribing patterns of non-steroidal anti-inflammatory drugs (NSAIDs) at outpatient departments of four hospitals. Biomedical Research. 2018; 29 (19). Access mode: https: www.alliedacademies.org/articles/prescribing-patterns-of-nonsteroidal-antiinflammatory-drugs-nsaids-at-outpatient-departments-of-four-hospitals-10928.html
- Schuijt M.P., Huntjens-Fleuren H.W., Vollaard E.J. et al. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br. J. Pharmacol. 2009; 157 (6): 931–4. Access mode: https: www.pubmed.ncbi.nlm.nih.gov/19466986
- Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking lowdose aspirin? Lancet. 2007; 370 (9605): 2138–51. Access mode: https: www.pubmed.ncbi.nlm.nih.gov/18156036
- Abu-Gharbieh E., Fahmy S., Basheti B.A.R.I. Prevalence of Aspirin Use and Its Concurrent Use with Ibuprofen among Two Middle Eastern Countries: Jordan and the UAE-A Cross Sectional Study. Jordan J. of Pharmaceutical Sciences. 2011; 4 (3): 155–65. Access mode: https: www.journals.ju.edu.jo/JJPS/article/view/2563
- The Arab science pedia. 2012. Access mode: https: www.arabsciencepedia.org/wiki/NSAID
- The Ultra-medica pharmaceutical in Syria. 2014–2020. Access mode: https: www.ultra-medica.org/index.php?ACT=5&Cid=5&id=383&Mod=2&LNG=Ar
- The Syrian clinic. 2020. Access mode: https: www.syrianclinic.com/component/content/article/121-the-musculoskeletal-system-drugs/1413-nsaids-.html
- The Syrian Researchers. 2019. Access mode: https: www.syr-res.com/subcat/22.html
- Al-Shidhani Zhang X., Donnan P., Bell S. et al. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology. 2017; 18: 256. Access mode: https: www.bit.ly/2ZI2abR
- McGettigan P., Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011; 8: e1001098. Access mode: https: www.pubmed.ncbi.nlm.nih.gov/21980265
- Deeks J.J., Smith L.A., Bradley M.D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for the treatment of osteoarthritis and rheumatoid arthritis: a systematic review of randomised controlled trials. B.M.J., 2002; 325: 619–23. Access mode: https: www.pubmed.ncbi.nlm.nih.gov/12242171